Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Positive Regulator Molecules02:39

Positive Regulator Molecules

5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Depletion of extracellular asparagine impairs self-reactive T cells and ameliorates autoimmunity in a murine model of multiple sclerosis.

eLife·2026
Same author

Distinct Source-Sink Patterns and Vertical Consumption of Alkyl and Aryl Organophosphate Esters in the Remote Ocean and Its Marginal Sea.

Environmental science & technology·2026
Same author

Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors.

bioRxiv : the preprint server for biology·2026
Same author

Epigenetic mechanisms of inflammatory memory in the central nervous system.

Nature immunology·2026
Same author

Efficacy and Safety of Bariatric Surgery in Acquired Hypothalamic Obesity: A Systematic Review and Individual Patient Data Meta-Analysis.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2026
Same author

Establishment of the China Elderly Comorbidity Medical Database (CECMed) and its application in machine learning-based prediction.

BMC geriatrics·2026

関連する実験動画

Updated: Jul 26, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

451

抗腫瘍免疫を調節するB細胞特異のチェックポイント分子

Lloyd Bod1,2,3,4, Yoon-Chul Kye1,2,3, Jingwen Shi1,2,5

  • 1Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA.

Nature
|June 21, 2023
PubMed
まとめ

研究者達は メラノーマの成長中に 拡大する特定のB細胞のサブセットを発見しました このTIM-1を発現するB細胞サブセットをターゲットにすることで,腫瘍の成長が著しく抑制され,抗腫瘍免疫が強化されました.

さらに関連する動画

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

447
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.7K

関連する実験動画

Last Updated: Jul 26, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

451
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

447
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.7K

科学分野:

  • 免疫学
  • 腫瘍学
  • 細胞生物学

背景:

  • 抗腫瘍免疫におけるB細胞の役割は完全に理解されていません.
  • 現在の免疫療法では 主にT細胞と自然殺人細胞を標的としています

研究 の 目的:

  • メラノーマの進行中の抗腫瘍免疫におけるB細胞の役割を調査する.
  • 腫瘍の成長と免疫反応に関与する特定のB細胞サブセットを特定する.

主な方法:

  • 高通量フローサイトメトリ
  • バルクと単細胞RNAのシーケンシング
  • B細胞受容体配列化
  • マウスにおけるB16F10メラノーマの成長中のB細胞の分析

主要な成果:

  • T細胞免疫グロブリンとムシン領域1 (TIM-1) を発現するB細胞の拡張サブセットを排水リンパ節で特定した.
  • このサブセットはPD-1,TIM-3,TIGIT,LAG-3のような共抑制分子も発現した.
  • B細胞におけるTIM- 1 (Havcr1) の選択的消去は,腫瘍の成長を抑制し,エフェクターT細胞の反応を強めた.
  • TIM- 1の喪失は1型インターフェロン反応を刺激し,B細胞の活性化,抗原の表示,共刺激を増加させ,腫瘍特異的エフェクターT細胞の拡大につながった.

結論:

  • TIM-1 を発現するB細胞は,抗腫瘍免疫の調節に重要な役割を果たします.
  • B細胞にTIM- 1を標的にすることで,適応免疫が強化され,腫瘍の成長が抑制されます.
  • これはB細胞を駆使した 癌の免疫療法における 新しい戦略を示しています